We observed increased methylation levels of BRD9 in BRCA, KIRC and KIRP (Figure S3A), and conversely reduced methylation levels in BLCA, ESCA, HNSC, LIHC, LUAD, LUSC, PAAD, prostate adenocarcinoma (PRAD), READ and UCEC (Figure S3A). The gene discussed is BRD9; the disease is prostate adenocarcinoma.